Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeation

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Salata OV. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2(1), 3 (2004).
  MedlineGoogle Scholar
• 2. Piktel E, Niemirowicz K, Wątek M, Wollny T, Deptuła P, Bucki R. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy. J. Nanobiotechnol. 14(1), 39 (2016).
  MedlineGoogle Scholar
• 3. Duhan J, Kumar R, Kumar N, Kaur P, Nehra K, Duhan S. Nanotechnology: the new perspective in precision agriculture. Biotech. Rep. 5, 11–23 (2017).
  Google Scholar
• 4. Chellappan DK, Panneerselvam J, Madheswaran T et al. Nanogels linked with chitosan: a perspective. Minerva. Med. 109(3), 254–255 (2018). • Discusses on the applications of nanogels linked with chitosan.
  MedlineGoogle Scholar
• 5. Chellappan DK, Ng ZY, Wong JY et al. Immunological axis of curcumin-loaded vesicular drug-delivery systems. Fut. Med. Chem. 10(8), 839–844 (2018).
  CASGoogle Scholar
• 6. Dua K, de Jesus Andreoli Pinto T, Chellappan DK, Gupta G, Bebawy M, Hansbro PM. Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases. Panmin. Med. 60(1), 35–36 (2018).
  MedlineGoogle Scholar
• 7. Chellappan DK, Hansbro PM, Dua K et al. Vesicular systems containing curcumin and their applications in respiratory disorders – a mini review. Pharm. Nanotechnol. 5(4), 250–254 (2017).
  Medline CASGoogle Scholar
• 8. Jeevanandam J, Chan Y, Danquah M. Nano-formulations of drugs: recent developments, impact and challenges. Biochimie 128–129, 99–112 (2016). • Discusses on the latest developments, impacts and challenges in nanotechnology and drug discovery.
  Medline CASGoogle Scholar
• 9. Ray A, Mandal A, Joseph M, Mitra A. Recent patents on nanoparticles and nanoformulations for cancer therapy. Recent. Pat. Drug. Deliv. Formulation. 10(1), 11–23 (2016).
  Medline CASGoogle Scholar
• 10. Dash T, Konkimalla V. Nanoformulations for delivery of biomolecules: focus on liposomal variants for siRNA delivery. Crit. Rev. Ther. Drug Carr. Sys. 30(6), 469–93 (2013).
  Medline CASGoogle Scholar
• 11. Awasthi R, Roseblade A, Hansbro PM, Rathbone MJ, Dua K, Bebawy M. Nanoparticles in cancer treatment: opportunities and obstacles. Curr. Drug. Targets. doi: 10.2174/1389450119666180326122831 (2018).
  MedlineGoogle Scholar
• 12. Awasthi R, Rathbone MJ, Hansbro PM, Bebawy M, Dua K. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology. Drug. Deliv. Transl. Res. 8(1), 97–110 (2018).
  Medline CASGoogle Scholar
• 13. Vicario-de-la-Torre M, Forcada J. The potential of stimuli-responsive nanogels in drug and active molecule delivery for targeted therapy. Gels 3(2), 16 (2017).
  Google Scholar
• 14. Zhang H, Zhai Y, Wang J, Zhai G. New progress and prospects: the application of nanogel in drug delivery. Mat. Sci. Engineer: C. 60, 560–568 (2016).
  Medline CASGoogle Scholar
• 15. Oh J, Drumright R, Siegwart D, Matyjaszewski K. The development of microgels/nanogels for drug delivery applications. Prog. Polymer. Sci. 33(4), 448–477 (2008). •• Discusses on the methods of development of nanogels for targeted delivery.
  CASGoogle Scholar
• 16. Zhang Q, Colazo J, Berg D, Mugo S, Serpe M. Multiresponsive nanogels for targeted anticancer drug delivery. Mol. Pharma. 14(8), 2624–2628 (2017).
  Medline CASGoogle Scholar
• 17. Vinogradov S. Nanogels in the race for drug delivery. Nanomedicine 5(2), 165–168 (2010).
  Medline CASGoogle Scholar
• 18. Quan S, Wang Y, Zhou A, Kumar P, Narain R. Galactose-based thermosensitive nanogels for targeted drug delivery of iodoazomycin arabinofuranoside (IAZA) for theranostic management of hypoxic hepatocellular carcinoma. Biomacromology 16(7), 1978–1986 (2015).
  Medline CASGoogle Scholar
• 19. Eckmann D, Composto R, Tsourkas A, Muzykantov V. Nanogel carrier design for targeted drug delivery. J. Mater. Chem. B. 2(46), 8085–8097 (2014). • Discusses on the applications of nanogel carrier design in the field of medicine.
  Medline CASGoogle Scholar
• 20. Gil M, Thambi T, Phan V, Kim S, Lee D. Injectable hydrogel-incorporated cancer cell-specific cisplatin releasing nanogels for targeted drug delivery. J. Mater. Chem. B. 5(34), 7140–7152 (2017).
  Medline CASGoogle Scholar
• 21. Yu J, Zhang Y, Sun W et al. Internalized compartments encapsulated nanogels for targeted drug delivery. Nanoscale 8(17), 9178–9184 (2016).
  Medline CASGoogle Scholar
• 22. Chacko R, Ventura J, Zhuang J, Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv. Drug. Del. Rev. 64(9), 836–851 (2012). • Discusses on the applications of nanogels in the field of medicine.
  Medline CASGoogle Scholar
• 23. Kang H, Trondoli A, Zhu G et al. Near-infrared light-responsive core–shell nanogels for targeted drug delivery. ACS. Nano 5(6), 5094–5099 (2011).
  Medline CASGoogle Scholar
• 24. Rampino A, Borgogna M, Blasi P, Bellich B, Cesàro A. Chitosan nanoparticles: preparation, size evolution and stability. Int. J. Pharm. 455(1–2), 219–28 (2013).
  Medline CASGoogle Scholar
• 25. Du H, Yang X, Zhai G. Design of chitosan-based nanoformulations for efficient intracellular release of active compounds. Nanomedicine 9(5), 723–740 (2014).
  Medline CASGoogle Scholar
• 26. Liu Z, Lv D, Liu S et al. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. PLoS One 8(4), e60190 (2013).
  Medline CASGoogle Scholar
• 27. Nagarwal R, Nath Singh P, Kant S, Maiti P, Pandit J. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study. Chem. Pharm. Bull. 59(2), 272–278 (2011).
  Medline CASGoogle Scholar
• 28. Islam P, Water J, Bohr A, Rantanen J. Chitosan-based nano-embedded microparticles: impact of nanogel composition on physicochemical properties. Pharmaceutics 9(1), 1 (2016).
  Google Scholar
• 29. Makita-Chingombe F, Kutscher H, DiTursi S, Morse G, Maponga C. Poly(lactic-co-glycolic) acid-chitosan dual loaded nanoparticles for antiretroviral nanoformulations. J. Drug Del. 2016, 3810175 (2016).
  MedlineGoogle Scholar
• 30. Brunel F, Véron L, Ladavière C, David L, Domard A, Delair T. Synthesis and structural characterization of chitosan nanogels. Langmuir 25(16), 8935–8943 (2009).
  Medline CASGoogle Scholar
• 31. Farag R, Mohamed R. Synthesis and characterization of carboxymethyl chitosan nanogels for swelling studies and antimicrobial activity. Molecules. 18(1), 190–203 (2012).
  MedlineGoogle Scholar
• 32. Lin C, Chen C, Lin Z, Fang J. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. J. Food. Drug. Anal. 25(2), 219–234 (2017).
  Medline CASGoogle Scholar
• 33. Yuan H, Chen C, Chai G, Du Y, Hu F. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol. Pharm. 10(5), 1865–1873 (2013).
  Medline CASGoogle Scholar
• 34. Chauhan B, Shimpi S, Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 26(2), 219–230 (2005).
  Medline CASGoogle Scholar
• 35. Behera A, Sahoo S. Preparation and evaluation of glibenclamide-loaded biodegradable nanoparticles. Trop. J. Pharm. Res. 11(3), (2012). • Describes the preparation and evaluation of glibenclamide nanoparticles.
  Google Scholar
• 36. Gelperina S, Kisich K, Iseman M, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Amer. J. Res. Crit. Care. Med. 172(12), 1487–1490 (2005).
  MedlineGoogle Scholar
• 37. Kadam R, Bourne D, Kompella U. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance. Drug. Met. Disp. 40(7), 1380–1388 (2012).
  Medline CASGoogle Scholar
• 38. Chitkara D, Nikalaje S, Mittal A, Chand M, Kumar N. Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug. Del. Transl. Res. 2(2), 112–123 (2012).
  Medline CASGoogle Scholar
• 39. Testa G, Gamba P, Badilli U et al. Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols. PLoS One 9(5), e96795 (2014).
  MedlineGoogle Scholar
• 40. Pool H, Quintanar D, Figueroa J et al. Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J. Nanomaterials 2012, 1–12 (2012).
  Google Scholar
• 41. Hendrawati A, Akhmad S, Sadewa A, Tasmini. The effect ofcombination of quercetin and glibenclamide on myocardial nuclear factor erythroid 2-related factor 2 (Nrf2) expression in Type 2 diabetic rat. Bangla. J. Med. Sci. 16(2), 302–306 (2017). •• Discusses on the synergistic therapeutic effect of glibenclamide and quercetin in diabetes.
  Google Scholar
• 42. Bhatia S. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. Nat. Poly. Drug. Del. Sys. 33–93 (2016).
  Google Scholar
• 43. Dangi RS, Shakya S. Preparation, optimization and characterization of PLGA nanoparticle. Intern. J. Pharm. Life Sci. 4(7), 2810–2818 (2013).
  CASGoogle Scholar
• 44. Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian. J. Pharm. Sci. 11(3), 404–416 (2016).
  Google Scholar
• 45. Madan JR, Sagar B, Chellappan DK, Dua K. Development and evaluation of transdermal organogels containing nicorandil. Antiinflamm. Antialler. Agents. Med. Chem. 12(3), 246–252 (2013).
  Medline CASGoogle Scholar
• 46. Madan JR, Ghuge NP, Dua K. Formulation and evaluation of proniosomes containing lornoxicam. Drug. Deliv. Transl. Res. 6(5), 511–518 (2016).
  Medline CASGoogle Scholar
• 47. Madan JR, Adokar BR, Dua K. Development and evaluation of in situ gel of pregabalin. Int. J. Pharm. Investig. 5(4), 226–233 (2015).
  Medline CASGoogle Scholar
• 48. Madan JR, Khude PA, Dua K. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int. J. Pharm. Investig. 4(2), 60–64 (2014).
  Medline CASGoogle Scholar
• 49. Dua K, Pabreja K, Ramana MV. Aceclofenac topical dosage forms: in vitro and in vivo characterization. Acta Pharm. 60(4), 467–478 (2010).
  Medline CASGoogle Scholar
• 50. Ali H, Hanafy A. Glibenclamide nanocrystals in a biodegradable chitosan patch for transdermal delivery: engineering, formulation, and evaluation. J. Pharm. Sci. 402–410 (2017).
  MedlineGoogle Scholar
• 51. Michaels A, Chandrasekaran S, Shaw J. Drug permeation through human skin: theory and in-vitro experimental measurement. AIChE. J. 21(5), 985–996 (1975).
  CASGoogle Scholar
• 52. Koukaras E, Papadimitriou S, Bikiaris D, Froudakis G. Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate. Mol. Pharm. 9(10), 2856–2862 (2012).
  Medline CASGoogle Scholar
• 53. De Pinho Neves A, Milioli C, Müller L, Riella H, Kuhnen N, Stulzer H. Factorial design as tool in chitosan nanoparticles development by ionic gelation technique. Coll. Surf A. Physicochem. Engineer. Asp. 445, 34–39 (2014).
  Google Scholar
• 54. Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Coll. Surf B. Biointer. 90, 21–27 (2012).
  Medline CASGoogle Scholar
• 55. Abioye A, Issah S, Kola-Mustapha A. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique-a tool for controlled transdermal delivery of ibuprofen. Inter. J. Pharm. 490(1–2), 112–130 (2015).
  Medline CASGoogle Scholar
• 56. Kunjachan S, Jose S. Understanding the mechanism of ionic gelation for synthesis of chitosan nanoparticles using qualitative techniques. Asian. J. Pharm. 4(2), 148 (2010). • Discusses on the important procedures in the synthesis of nanogels by ionic gelation method.
  CASGoogle Scholar
• 57. Yoksan R, Jirawutthiwongchai J, Arpo K. Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes. Coll. Surf B. Biointer. 76(1), 292–297 (2010).
  Medline CASGoogle Scholar
• 58. Ribeiro A, Silva C, Ferreira D, Veiga F. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur. J. Pharm. Sci. 25(1), 31–40 (2005).
  Medline CASGoogle Scholar
• 59. Juttulapa M, Piriyaprasarth S, Takeuchi H, Sriamornsak P. Effect of high-pressure homogenization on stability of emulsions containing zein and pectin. Asian. J. Pharm. Sci. 12(1), 21–7 (2017).
  MedlineGoogle Scholar
• 60. Katas H, Alpar H. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Cont. Rel. 115(2), 216–225 (2006).
  Medline CASGoogle Scholar
• 61. Islam P, Water J, Bohr A, Rantanen J. Chitosan-based nano-embedded microparticles: impact of nanogel composition on physicochemical properties. Pharmaceutics 9(1), 1 (2016).
  Google Scholar
• 62. Vedakumari W, Ayaz N, Karthick A, Senthil R, Sastry T. Quercetin impregnated chitosan–fibrin composite scaffolds as potential wound dressing materials - fabrication, characterization and in vivo analysis. Eur. J. Pharm. Sci. 97, 106–112 (2017).
  Medline CASGoogle Scholar
• 63. Mohammadpour Dounighi N, Eskandari R, Avadi MR, Zolfagharian H, Mir Mohammad Sadeghi A, Rezayat M. Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system. J. Ven. Ani. Tox. Incl. Trop. Dis. 18(1), 44–52 (2012).
  Google Scholar
• 64. Ruiz-Caro R, Veiga-Ochoa M. Characterization and dissolution study of chitosan freeze-dried systems for drug controlled release. Molecules 14(11), 4370–4386 (2009).
  Medline CASGoogle Scholar
• 65. Shaik HR, Haribabu R, Md Khajamohiddin et al. Transdermal drug delivery system-simplified medication regimen – a review. Res. J. Pharm. Biol. Chem. 2(4), 223–228 (2011).
  CASGoogle Scholar